Australia Transfection Market to 2032
Overview
The Australia Transfection Market is expected to reach a 43.85 USD Billion by 2032 and is projected to grow at a CAGR of 16.25% from 2025 to 2032.
Revenue, 2024 (USD Billion)
19.79
Forecast, 2032 (USD Billion)
43.85
CAGR, 2024 - 2032
16.25%
Report Coverage
Australia
Australia Transfection Market 2018-2032 USD Billion
Australia Transfection Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 19.79 USD Billion
- Projected Market Size (2032): 43.85 USD Billion
- CAGR (2025-2032): 16.25%
Key Findings of Australia Transfection Market
- The Australia Transfection Market was valued at 43.85 USD Billion in 2024.
- The Australia Transfection Market is likely to grow at a CAGR of 16.25% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Transient Transfection in Type Segment accounted for the largest share of the market with a revenue of 26.51 USD Billion
- The fastest growing segment Small Interfering Rna (SIRNA) in Molecule Segment grew Fastest with a CAGR of 19.00% during the forecast period from 2024 to 2032.
Australia Transfection Market Scope
Australia Transfection Market Segmentation & Scope
Type
- Stable Transection
- Transient Transfection
Methods
- Viral Methods
- Non-viral Methods
Application
- Type
- Industry
Molecule
- Others
- Ribonucleoprotein Complexes (RNPS)
- Dna Oligonucleotides
- Proteins
- Small Interfering Rna (SIRNA)
- Plasmid DNA
Organism
- Bacteria
- Virus
- Fungi
- Plants
- Mammalian Cells
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
End User
- Others
- Clinical Labs
- Hospitals
- Academia
- Contract Manufacturing Organization/ Contract Development And Manufacturing Organization (CMOS/CDMOS)
- Contract Research Organizations (CROS)
- Biopharma
Stages
- Commercial
- Clinical Phases
- Preclinical
- Research
Products
- Instrument
- Reagents & Kits
Australia Transfection Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 19.79 USD Billion |
| Market Value in 2032 | 43.85 USD Billion |
| CAGR (2025-2032) | 16.25% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type, Methods, Application, Molecule, Organism, Distribution Channel, End User, Stages, Products |
Regional Insights:
-
Leading Market (2024-2032): Australia, leading in terms of revenue 19.79 USD Billion in 2024
- Key Country: Australia, leading in terms of revenue with value of 19.79 USD Billion in 2024.
Segments and Scope
-
Australia Transfection Market to 2032, By Type
- Transient Transfection is the largest segment in Australia Transfection Market to 2032 with a revenue of 26.51 USD Billion in the year 2024.
- Transient Transfection is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 17.43 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Methods
- Non-viral Methods is the largest segment in Australia Transfection Market to 2032 with a revenue of 15.77 USD Billion in the year 2024.
- Viral Methods is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 15.65 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Application
- Type is the largest segment in Australia Transfection Market to 2032 with a revenue of 19.79 USD Billion in the year 2024.
- Type is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 16.25 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Molecule
- Plasmid DNA is the largest segment in Australia Transfection Market to 2032 with a revenue of 7.87 USD Billion in the year 2024.
- Small Interfering Rna (SIRNA) is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 14.90 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Organism
- Mammalian Cells is the largest segment in Australia Transfection Market to 2032 with a revenue of 12.10 USD Billion in the year 2024.
- Mammalian Cells is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 17.01 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Australia Transfection Market to 2032 with a revenue of 17.08 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 16.80 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By End User
- Biopharma is the largest segment in Australia Transfection Market to 2032 with a revenue of 12.43 USD Billion in the year 2024.
- Biopharma is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 17.13 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Stages
- Research is the largest segment in Australia Transfection Market to 2032 with a revenue of 12.86 USD Billion in the year 2024.
- Clinical Phases is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 16.58 % in forecast period 2025-2032.
-
Australia Transfection Market to 2032, By Products
- Reagents & Kits is the largest segment in Australia Transfection Market to 2032 with a revenue of 15.77 USD Billion in the year 2024.
- Reagents & Kits is the Fastest growing segment in Australia Transfection Market to 2032 with a Growth rate of 16.82 % in forecast period 2025-2032.
Australia Transfection Market Company Share Analysis
| Company Name |
|
||
| Lonza | |||
| Thermo Fisher Scientific Inc. | |||
| Takara Bio Inc. | |||
| Qiagen | |||
| Promega Corporation. | |||
Australia Transfection Market Geographical Sales Distribution, 2018-2032 USD Billion
Australia Transfection Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia Transfection Market is segmented based on Segmentation Type, Methods, Application, Molecule, Organism, Distribution Channel, End User, Stages, Products.
Australia Transfection Market was valued at USD 19.79(Revenue in USD Billion) in 2020.
Australia Transfection Market is projected to grow at a CAGR of 16.25% during the forecast period of 2024 to 2032.
The Transient Transfection segment is expected to dominate the Australia Transfection Market, holding a largest market share of 26.51 USD Billion in 2024
Australia Transfection Market Scope
Australia Transfection Market Segmentation & Scope
Type
- Stable Transection
- Transient Transfection
Methods
- Viral Methods
- Non-viral Methods
Application
- Type
- Industry
Molecule
- Others
- Ribonucleoprotein Complexes (RNPS)
- Dna Oligonucleotides
- Proteins
- Small Interfering Rna (SIRNA)
- Plasmid DNA
Organism
- Bacteria
- Virus
- Fungi
- Plants
- Mammalian Cells
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
End User
- Others
- Clinical Labs
- Hospitals
- Academia
- Contract Manufacturing Organization/ Contract Development And Manufacturing Organization (CMOS/CDMOS)
- Contract Research Organizations (CROS)
- Biopharma
Stages
- Commercial
- Clinical Phases
- Preclinical
- Research
Products
- Instrument
- Reagents & Kits
Frequently Asked Questions
The Australia Transfection Market is segmented based on Segmentation Type, Methods, Application, Molecule, Organism, Distribution Channel, End User, Stages, Products.
Australia Transfection Market was valued at USD 19.79(Revenue in USD Billion) in 2020.
Australia Transfection Market is projected to grow at a CAGR of 16.25% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Transfection Market for final year is USD 43.85 (USD Billion).
Australia Transfection Market Company Profiling
Frequently Asked Questions
The Australia Transfection Market is segmented based on Segmentation Type, Methods, Application, Molecule, Organism, Distribution Channel, End User, Stages, Products.
Australia Transfection Market was valued at USD 19.79(Revenue in USD Billion) in 2020.
Australia Transfection Market is projected to grow at a CAGR of 16.25% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Transfection Market for final year is USD 43.85 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.